Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma

NCT02406144 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT02406144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02406144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma
Lead sponsor
PETHEMA Foundation
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2014
Completion date
November 30, 2017
Enrollment
316 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma